In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis
Nadjet Gacem(Centre National de la Recherche Scientifique), Gianvito Martino(Vita-Salute San Raffaele University), Cyrille Deboux(Centre National de la Recherche Scientifique), Cristina Agresti(Istituto Superiore di Sanità), M. Lévy(Inserm), Francesca Ruffini(Vita-Salute San Raffaele University), Norbert Goebels(Heinrich Heine University Düsseldorf), Radmila Panic(Centre National de la Recherche Scientifique), Ivano Eberini(University of Milan), Beatriz García-Díaz(Centre National de la Recherche Scientifique), Alessia Formato(Istituto Superiore di Sanità), Jérémy Chazot(Centre National de la Recherche Scientifique), Farina Windener(University Hospital Münster), S. Baranzini(University of California, San Francisco), Elif Nur Yılmaz(Istanbul Medipol University), Svetlana Bezukladova(Vita-Salute San Raffaele University), Alberto Bresciani(University of Bergamo), Frauke Zipp(Johannes Gutenberg University Mainz), Elena Brambilla(Vita-Salute San Raffaele University), Jack P. Antel(Montreal Neurological Institute and Hospital), Linda K Ottoboni(Vita-Salute San Raffaele University), Anne Baron-Van Evercooren(Centre National de la Recherche Scientifique), Qiao-Ling Cui(Montreal Neurological Institute and Hospital), Paola Panina-Bordignon(Vita-Salute San Raffaele University), Karthik Soman(University of California, San Francisco), Raquel Guerrero González(University Hospital Münster), Brahim Nait-Oumesmar(Centre National de la Recherche Scientifique), Tala Karam(Centre National de la Recherche Scientifique), Stefanie Albrecht(University Hospital Münster), Tanja Kuhlmann(University Hospital Münster), Stefania Olla(Institute of Genetic and Biomedical Research)
Cited by 3
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy
|Nature Genetics|2020|1.3k
Multiple Sclerosis Severity Score
|Neurology|2005|959
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Class II HLA interactions modulate genetic risk for multiple sclerosis
|Nature Genetics|2015|428